864669-99-8

Upstream product

• 864669-97-6 (4-chloro-6-methyl-pyrimidin-2-yl)-(2,4,6-trimethyl-phenyl)-amine 
• 616-24-0 3-aminopentane 

Downstream Products

• 864670-01-9 N₄-(1-ethyl-propyl)-5-iodo-6-methyl-N₂-(2,4,6-trimethyl-phenyl)-pyrimidine-2,4-diamine 

Relevant academic research and scientific papers

PYRROLOPYRIMIDINE DERIVATIVES

According to the present invention, there is provided an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastro-intesinal diseases, drug dependence, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alpecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, pain, etc. A pyrrolopyrimidine derivative represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.